British journal of clinical pharmacology
Cardiovascular benefits of early sodium-glucose cotransporter 2 inhibitor use for diabetics with acute myocardial infarction: A nationwide cohort study.
Sheng-Fan Wang, Tzu-Kuan Chan, Yu-Hsuan Lee, Yu-Shiuan Wang, Chian-Ying Chou, Yuh-Lih Chang, Hui-Ju Tsai, Hsin-Chen Lee, Gregory Y H Lip, Chern-En Chiang, Chen-Huan Chen, Hao-Min Cheng
Published: 202510.1002/bcp.70416
Abstract
AIMS: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have well-documented cardiovascular benefits. However, the cardiovascular benefits of early SGLT2i use in diabetics experiencing acute myocardial infarction (MI) remain unclear. METHODS: To eva…
Preview only. Read the full abstract at the source